AMGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF ABP 654, BIOSIMILAR
Primary Efficacy Analysis Demonstrates no Clinically Meaningful Differences Compared to STELARA THOUSAND OAKS, Calif., April 18, ...
Read morePrimary Efficacy Analysis Demonstrates no Clinically Meaningful Differences Compared to STELARA THOUSAND OAKS, Calif., April 18, ...
Read moreSAN JOSE, Calif., April 11, 2022 /PRNewswire/ -- Quantum Corporation (NASDAQ: QMCO) announced today preliminary revenue ...
Read moreBy John Vandermosten, CFA NYSE:PLX READ THE FULL PLX RESEARCH REPORT Topline Results from BALANCE Protalix ...
Read moreStock market this week: After the end of a volatile week, stock market is gearing up ...
Read moreTheNewswire - March 29, 2022 - Renforth Resources Inc. RFR RFR RFHRF (FSE:9RR) ("Renforth" or the ...
Read moreErasca (NASDAQ:ERAS - Get Rating) posted its quarterly earnings data on Thursday. The company reported ($0.26) ...
Read more© 2022 TheDailyStock.News